Vyant Bio to Present at the LD Micro Main Event XV on Wednesday, October 26, 2022
24. Oktober 2022 16:15 ET
|
Vyant Bio, Inc.
-To Discuss its Novel Drug Discovery Platform that is Accelerating the Process of Finding Cures for Neurogenerative Diseases CHERRY HILL, N.J., Oct. 24, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc....
Vyant Bio to Present at the H.C. Wainwright 24th Annual Global Investment Conference
31. August 2022 08:00 ET
|
Vyant Bio, Inc.
CHERRY HILL, N.J., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...
Vyant Bio Postpones Second Quarter Investor Conference Call and Webcast
15. August 2022 08:05 ET
|
Vyant Bio, Inc.
CHERRY HILL, N.J., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...
Vyant Bio Retains Skyline Corporate Communications Group, LLC to Provide Investor Relations Services
01. Juni 2022 18:05 ET
|
Vyant Bio, Inc.
CHERRY HILL, N.J., June 01, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...
Vyant Bio Announces Investor Conference Call and Webcast for the First Quarter 2022
10. Mai 2022 16:01 ET
|
Vyant Bio, Inc.
CHERRY HILL, N.J., May 10, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...
Vyant Bio Issues Letter to Shareholders
01. März 2022 08:30 ET
|
Vyant Bio, Inc.
Cherry Hill, NJ, March 01, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, the “Company”) (Nadsaq:VYNT), is an innovative biotechnology company focused on identifying unique biological...